These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17046253)

  • 21. Isolation of coniferyl esters from Capsicum baccatum L., and their enzymatic preparation and agonist activity for TRPV1.
    Kobata K; Tate H; Iwasaki Y; Tanaka Y; Ohtsu K; Yazawa S; Watanabe T
    Phytochemistry; 2008 Mar; 69(5):1179-84. PubMed ID: 18190936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
    Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
    Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational studies on resiniferatoxin (RTX), an ultrapotent vanilloid agonist.
    Victory SF; Appendino G; Vander Velde DG
    Bioorg Med Chem; 1998 Feb; 6(2):223-9. PubMed ID: 9547945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
    Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
    Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
    Doherty EM; Fotsch C; Bannon AW; Bo Y; Chen N; Dominguez C; Falsey J; Gavva NR; Katon J; Nixey T; Ognyanov VI; Pettus L; Rzasa RM; Stec M; Surapaneni S; Tamir R; Zhu J; Treanor JJ; Norman MH
    J Med Chem; 2007 Jul; 50(15):3515-27. PubMed ID: 17585750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
    Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
    J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient receptor potential vanilloid receptor-1 does not contribute to slowly adapting airway receptor activation by inhaled ammonia.
    Wu M; Qin C; Foreman RD; Farber JP
    Auton Neurosci; 2007 May; 133(2):121-7. PubMed ID: 17169618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
    Wong GY; Gavva NR
    Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.
    Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM
    Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
    Liu HT; Kuo HC
    BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters.
    Flores CM; Vasko MR
    Mol Interv; 2010 Jun; 10(3):137-40. PubMed ID: 20539032
    [No Abstract]   [Full Text] [Related]  

  • 32. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
    Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D
    Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of vanilloid transient receptor potential cation channels.
    Vriens J; Appendino G; Nilius B
    Mol Pharmacol; 2009 Jun; 75(6):1262-79. PubMed ID: 19297520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility properties.
    Doherty EM; Retz D; Gavva NR; Tamir R; Treanor JJ; Norman MH
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1830-4. PubMed ID: 18299195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Tamayo N; Liao H; Stec MM; Wang X; Chakrabarti P; Retz D; Doherty EM; Surapaneni S; Tamir R; Bannon AW; Gavva NR; Norman MH
    J Med Chem; 2008 May; 51(9):2744-57. PubMed ID: 18386885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration.
    Waning J; Vriens J; Owsianik G; Stüwe L; Mally S; Fabian A; Frippiat C; Nilius B; Schwab A
    Cell Calcium; 2007 Jul; 42(1):17-25. PubMed ID: 17184838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists.
    Kim HS; Jin MK; Kang SU; Lim JO; Tran PT; Hoang VH; Ann J; Ha TH; Pearce LV; Pavlyukovets VA; Blumberg PM; Lee J
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2685-8. PubMed ID: 24794110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caged capsaicins: New tools for the examination of TRPV1 channels in somatosensory neurons.
    Gilbert D; Funk K; Dekowski B; Lechler R; Keller S; Möhrlen F; Frings S; Hagen V
    Chembiochem; 2007 Jan; 8(1):89-97. PubMed ID: 17154194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.